On January 15, 2021, the U.S. Food and Drug Administration (FDA) approved fam-trastuzumab deruxtecan-nxki (Enhertu®) for adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal (GEJ) adenocarcinoma who have received a prior trastuzumab-based regimen.
Cancer care is always changing, new science is constantly developing, and oncology nurses must work to keep up. ONS’s philosophy is that every nurse has room to develop knowledge, practice, and research. As an organization, we embody a commitment to lifelong learning and professional development because we understand that both are crucial to oncology nursing and patient outcomes.
Imagery is a mind-body practice with deep historical roots. It uses imagination to recreate mental images, sounds, smells and even tastes to help achieve relaxation and to promote healing. Guided imagery can be learned in an interactive manner from a licensed practitioner or from books and self-help tapes. Repeating the practice results in a conditioning effect that can empower the individual to use it whenever needed.
On January 14, 2021, the U.S. Food and Drug Administration (FDA) approved crizotinib (Xalkori®) for pediatric patients aged one year or older and young adults with relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is anaplastic lymphoma kinase (ALK) positive. The safety and efficacy of crizotinib have not been established in older adults with relapsed or refractory, systemic ALK-positive ALCL.
The World Health Organization’s Year of the Nurse didn’t go as planned in 2020. Instead, Americans were forced to navigate unprecedented stressors, but among the conflict, fear, and uncertainty, nursing remained the most trusted profession in the United States, earning a record-breaking 89% score on the 2020 Gallup Honesty and Ethics poll, four percentage points greater than the profession’s 2019 rating. Trust has to be earned, and not only have nurses done so, but they continue to foster and grow trust for in an unparalleled way.
Quick: what’s your first reaction when you hear the word criticism? Do you brace yourself for feelings of failure and put up a defensive wall? It’s hard to respond otherwise, but try to look at it differently. Criticism can be positive if we accept it with class and let it help us gain knowledge about ourselves.
Patients with cancer who experience unexpected and long-lasting treatment outcomes are considered exceptional responders, but researchers and clinicians had no insight as to why the patients did so well with treatment. Results of a new study now show that genomic characterizations of cancer can uncover genetic alterations that may contribute to the phenomenon, researchers reported in Cancer Cell.
Painful skin reactions may develop in as many as 95% of patients receiving radiotherapy treatments for cancer. Patients report that it affects their quality of life and that purchasing interventions to soothe their skin increases their out-of-pocket costs. Supporting patients who experience the side effect is critical for their well-being.
During its quarterly two-day meeting on November 5–6, 2020, the ONS Board of Directors held a joint session with the Oncology Nursing Certification Corporation and Oncology Nursing Foundation boards of directors. The ONS Board also completed budget approvals and ongoing assessment of the membership, among other work. Highlights from those actions follow, and ONS members can review the full meeting minutes at ons.org/board-minutes.
When I sat for the very first Certified Pediatric Oncology Nurse (CPON®) examination through the Oncology Nursing Certification Corporation in 1993, I had no idea how obtaining my certification would positively affect my career. I was one of four nurses from the University of North Carolina Hospitals who felt strongly as a group that we could and should pursue our CPON® certification, and we all passed the exam together.